149 related articles for article (PubMed ID: 14729098)
21. Calcium channel inhibitor, verapamil, inhibits the voltage-dependent K+ channels in rabbit coronary smooth muscle cells.
Ko EA; Park WS; Son YK; Ko JH; Choi TH; Jung ID; Park YM; Hong DH; Kim N; Han J
Biol Pharm Bull; 2010; 33(1):47-52. PubMed ID: 20045934
[TBL] [Abstract][Full Text] [Related]
22. The class III anti-arrhythmic agent, amiodarone, inhibits voltage-dependent K(+) channels in rabbit coronary arterial smooth muscle cells.
Li H; Kim HS; Kim HW; Shin SE; Jung WK; Ha KS; Han ET; Hong SH; Firth AL; Bae YM; Choi IW; Park WS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):713-21. PubMed ID: 27030392
[TBL] [Abstract][Full Text] [Related]
23. The calmodulin inhibitor and antipsychotic drug trifluoperazine inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.
Hong DH; Son YK; Li H; Jung ID; Park YM; Jung WK; Kim HS; Choi IW; Park WS
Biochem Biophys Res Commun; 2014 Jan; 443(1):321-5. PubMed ID: 24316213
[TBL] [Abstract][Full Text] [Related]
24. Expression of voltage-dependent K(+) channel genes in mesenteric artery smooth muscle cells.
Xu C; Lu Y; Tang G; Wang R
Am J Physiol; 1999 Nov; 277(5):G1055-63. PubMed ID: 10564112
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of voltage-dependent K
Li H; Zhuang W; Seo MS; An JR; Yang Y; Zha Y; Liang J; Xu ZX; Park WS
Eur J Pharmacol; 2021 Aug; 904():174158. PubMed ID: 33971179
[TBL] [Abstract][Full Text] [Related]
26. The effect of tyrosine kinase inhibitor genistein on voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.
Ko EA; Park WS; Son YK; Kim DH; Kim N; Kim HK; Choi TH; Jung ID; Park YM; Han J
Vascul Pharmacol; 2009; 50(1-2):51-6. PubMed ID: 18952004
[TBL] [Abstract][Full Text] [Related]
27. W-7 inhibits voltage-dependent K(+) channels independent of calmodulin activity in rabbit coronary arterial smooth muscle cells.
Li H; Choi IW; Hong DH; Son YK; Na SH; Jung WK; Firth AL; Jung ID; Park YM; Park WS
Eur J Pharmacol; 2015 Mar; 750():14-9. PubMed ID: 25617796
[TBL] [Abstract][Full Text] [Related]
28. Suppression of voltage-gated K
Seo MS; An JR; Jung HS; Kang M; Heo R; Han ET; Yang SR; Park H; Jung WK; Choi IW; Bae YM; Na SH; Park WS
Eur J Pharmacol; 2021 Jan; 891():173707. PubMed ID: 33137332
[TBL] [Abstract][Full Text] [Related]
29. Effects of the PKC inhibitors chelerythrine and bisindolylmaleimide I (GF 109203X) on delayed rectifier K+ currents.
Harmati G; Papp F; Szentandrássy N; Bárándi L; Ruzsnavszky F; Horváth B; Bányász T; Magyar J; Panyi G; Krasznai Z; Nánási PP
Naunyn Schmiedebergs Arch Pharmacol; 2011 Feb; 383(2):141-8. PubMed ID: 21120453
[TBL] [Abstract][Full Text] [Related]
30. Atypical antipsychotic olanzapine inhibits voltage-dependent K
Kang M; An JR; Seo MS; Jung HS; Heo R; Park H; Song G; Jung WK; Choi IW; Park WS
Pharmacol Rep; 2021 Dec; 73(6):1724-1733. PubMed ID: 34146337
[TBL] [Abstract][Full Text] [Related]
31. Thromboxane A2-induced inhibition of voltage-gated K+ channels and pulmonary vasoconstriction: role of protein kinase Czeta.
Cogolludo A; Moreno L; Bosca L; Tamargo J; Perez-Vizcaino F
Circ Res; 2003 Oct; 93(7):656-63. PubMed ID: 12970114
[TBL] [Abstract][Full Text] [Related]
32. Serotonin depolarizes the membrane potential in rat mesenteric artery myocytes by decreasing voltage-gated K+ currents.
Bae YM; Kim A; Kim J; Park SW; Kim TK; Lee YR; Kim B; Cho SI
Biochem Biophys Res Commun; 2006 Aug; 347(2):468-76. PubMed ID: 16828462
[TBL] [Abstract][Full Text] [Related]
33. The muscarinic receptor antagonist tolterodine inhibits voltage-dependent K
Seo MS; An JR; Jung HS; Jung WK; Choi IW; Na SH; Park H; Bae YM; Park WS
Eur J Pharmacol; 2020 Mar; 870():172921. PubMed ID: 31935397
[TBL] [Abstract][Full Text] [Related]
34. Blockade of voltage-dependent K
Li H; Shin SE; An JR; Seo MS; Ha KS; Han ET; Hong SH; Firth AL; Lee DS; Yim MJ; Lee JM; Choi G; Choi IW; Park WS
J Pharmacol Sci; 2018 May; 137(1):61-66. PubMed ID: 29752209
[TBL] [Abstract][Full Text] [Related]
35. Protriptyline, a tricyclic antidepressant, inhibits voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.
An JR; Kang H; Li H; Seo MS; Jung HS; Jung WK; Choi IW; Ryu SW; Park H; Bae YM; Ryu SM; Park WS
Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):320-327. PubMed ID: 32060505
[TBL] [Abstract][Full Text] [Related]
36. Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle.
Holland M; Langton PD; Standen NB; Boyle JP
Br J Pharmacol; 1996 Jan; 117(1):119-29. PubMed ID: 8825352
[TBL] [Abstract][Full Text] [Related]
37. The PPARα activator fenofibrate inhibits voltage-dependent K
Li H; Shin SE; Seo MS; An JR; Jung WK; Ha KS; Han ET; Hong SH; Bang H; Bae YM; Firth AL; Choi IW; Park WS
Eur J Pharmacol; 2017 Oct; 812():155-162. PubMed ID: 28716724
[TBL] [Abstract][Full Text] [Related]
38. The inhibitory effect of ziprasidone on voltage-dependent K
An JR; Seo MS; Jung HS; Heo R; Kang M; Ha KS; Park H; Park WS
Biochem Biophys Res Commun; 2020 Aug; 529(2):191-197. PubMed ID: 32703410
[TBL] [Abstract][Full Text] [Related]
39. Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance.
Mackie AR; Brueggemann LI; Henderson KK; Shiels AJ; Cribbs LL; Scrogin KE; Byron KL
J Pharmacol Exp Ther; 2008 May; 325(2):475-83. PubMed ID: 18272810
[TBL] [Abstract][Full Text] [Related]
40. Alterations of voltage-dependent K(+) channels in the mesenteric artery during the early and chronic phases of diabetes.
Hong da H; Li H; Kim HW; Kim HS; Son YK; Yang SR; Park JR; Ha KS; Han ET; Hong SH; Firth AL; Na SH; Park WS
Clin Exp Pharmacol Physiol; 2016 Sep; 43(9):808-17. PubMed ID: 27218229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
